Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Receivables - Net (2016 - 2021)

Viridian Therapeutics, Inc.\DE (VRDN) has 8 years of Receivables - Net data on record, last reported at $1.0 million in Q3 2021.

  • For Q3 2021, Receivables - Net rose 1654.39% year-over-year to $1.0 million; the TTM value through Sep 2021 reached $1.0 million, up 1654.39%, while the annual FY2019 figure was $108000.0, 350.0% up from the prior year.
  • Receivables - Net reached $1.0 million in Q3 2021 per VRDN's latest filing, up from $57000.0 in the prior quarter.
  • Across five years, Receivables - Net topped out at $4.8 million in Q1 2018 and bottomed at $4000.0 in Q1 2020.
  • Average Receivables - Net over 5 years is $862600.0, with a median of $539000.0 recorded in 2017.
  • Peak YoY movement for Receivables - Net: skyrocketed 7180.0% in 2017, then crashed 99.88% in 2019.
  • A 5-year view of Receivables - Net shows it stood at $1.5 million in 2017, then tumbled by 98.35% to $24000.0 in 2018, then surged by 3979.17% to $979000.0 in 2019, then tumbled by 94.18% to $57000.0 in 2020, then soared by 1654.39% to $1.0 million in 2021.
  • Per Business Quant database, its latest 3 readings for Receivables - Net were $1.0 million in Q3 2021, $57000.0 in Q3 2020, and $248000.0 in Q2 2020.